Trials / Recruiting
RecruitingNCT06196515
Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication
Evaluation of the Antibacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication: A Randomized Clinical Trial
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- British University In Egypt · Academic / Other
- Sex
- All
- Age
- 21 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the anti-bacterial potential of Nano Calcium Hydroxide as an intracanal medication in primary endodontic treatment of permanent molars.
Detailed description
This study is conducted to evaluate the bacterial reduction capability of hydrogel loaded with Nano Calcium Hydroxide and paste form of nano and conventional calcium hydroxide as an intracanal medication. The hydrogel will be synthesized in a new rapid in situ form that can turn from liquid into gel when reaching body temperature. The efficacy of bacterial reduction will be compared with Nano Calcium Hydroxide and conventional Calcium Hydroxide in paste form. The evaluation is to be done by quantitative microbiological assessment of samples which are gained from the root canal before and after intracanal medication placement in roots of permanent molars, having PAI score ≥ 2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium hydroxide | placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week. |
| DRUG | nano calcium hydroxide | placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week. |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2025-09-01
- Completion
- 2025-12-01
- First posted
- 2024-01-09
- Last updated
- 2024-08-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06196515. Inclusion in this directory is not an endorsement.